Renibus Therapeutics secures $47M funding to advance promising drug for postoperative complications following cardiothoracic surgery
Renibus Therapeutics, a clinical-stage biopharmaceutical company based in Southlake, Texas, has successfully raised $47 million in funding to advance the ...